« PreviousNext »American Journal of Ophthalmology
Volume 142, Issue 4 , Pages 576.e1-576.e8, October 2006
Volume 142, Issue 4 , Pages 576.e1-576.e8, October 2006
Baseline Optical Coherence Tomography Predicts the Development of Glaucomatous Change in Glaucoma Suspects
To access this article, please choose from the options below
Supported in part by NIH Grants EY11008 (LMZ), EY08208 (PAS), and MEC/CAPES grant BEX2230/04-6 (IMT). Participant retention incentive grants in the form of glaucoma medication at no cost: Alcon Laboratories Inc (Fort Worth, Texas), Allergan (Irvine, California), Pfizer Inc (New York, New York), and SANTEN Inc (Napa, California).
PII: S0002-9394(06)00580-0
doi:10.1016/j.ajo.2006.05.004
© 2006 Elsevier Inc. All rights reserved.
« PreviousNext »American Journal of Ophthalmology
Volume 142, Issue 4 , Pages 576.e1-576.e8, October 2006
Volume 142, Issue 4 , Pages 576.e1-576.e8, October 2006
